Ebrahim Eftekhar
Impact in
-
- Blood Pressure and Hypertension Studies
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
Papers in
-
- MicroRNA in disease regulation 7
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Co-authors
- Fayezeh Samari (3 shared papers)Saeed Yousefinejad (3 shared papers)Fakhraddin Naghibalhossaini (4 shared papers)Amin Reza Nikpoor (7 shared papers)Farideh Jalali Mashayekhi (4 shared papers)Seyed Hamid Moosavy (6 shared papers)Amin Ramezani (3 shared papers)Hesam Alizade (4 shared papers)
- Journals
- The Lancet (5 papers)Nature (3 papers)Molecular Biology Reports (3 papers)PLoS ONE (2 papers)Trials (2 papers)
- Partner nations
- IranCanadaSwitzerland
In The Last Decade
Ebrahim Eftekhar
93 papers receiving 5.9k citations
Ebrahim Eftekhar's Hit Papers
Peers
Comparison fields: 5 of 158
- Cardiology and Cardiovascular Medicine 1.6k
- Endocrinology, Diabetes and Metabolism 664
- Family Practice 90
- Nutrition and Dietetics 291
- Public Health, Environmental and Occupational Health 724
Countries citing papers authored by Ebrahim Eftekhar
This map shows the geographic impact of Ebrahim Eftekhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebrahim Eftekhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebrahim Eftekhar more than expected).
Fields of papers citing papers by Ebrahim Eftekhar
This network shows the impact of papers produced by Ebrahim Eftekhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebrahim Eftekhar. The network helps show where Ebrahim Eftekhar may publish in the future.
Co-authors
The 25 scholars most cited alongside Ebrahim Eftekhar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants Hit paper breakdown → | 2021 | 2568 |
| 2 | Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults Hit paper breakdown → | 2024 | 1305 |
| 3 | Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants Hit paper breakdown → | 2024 | 516 |
| 4 | Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants Hit paper breakdown → | 2020 | 311 |
| 5 | Repositioning of the global epicentre of non-optimal cholesterol Hit paper breakdown → | 2020 | 223 |
| 6 | 2021 | 118 | |
| 7 | 2018 | 94 | |
| 8 | 2021 | 63 | |
| 9 | 2017 | 51 | |
| 10 | 2023 | 49 | |
| 11 | 2017 | 46 | |
| 12 | 2019 | 46 | |
| 13 | Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis. | 2009 | 41 |
| 14 | 2023 | 37 | |
| 15 | 2013 | 35 | |
| 16 | 2020 | 33 | |
| 17 | 2024 | 27 | |
| 18 | 2016 | 26 | |
| 19 | 2019 | 25 | |
| 20 | 2023 | 24 |
About Ebrahim Eftekhar
Ebrahim Eftekhar is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics, Oncology and Biochemistry, having authored 99 papers that have together received 6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Epigenetics and DNA Methylation (6 papers), Obesity, Physical Activity, Diet (6 papers), Nanoparticles: synthesis and applications (5 papers), Magnesium in Health and Disease (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.6k citations), Endocrinology, Diabetes and Metabolism (664 citations), Family Practice (90 citations), Nutrition and Dietetics (291 citations) and Public Health, Environmental and Occupational Health (724 citations). Ebrahim Eftekhar has collaborated with scholars based in Iran, Canada and Switzerland. Frequent co-authors include Fayezeh Samari, Saeed Yousefinejad, Fakhraddin Naghibalhossaini, Amin Reza Nikpoor, Farideh Jalali Mashayekhi, Seyed Hamid Moosavy, Amin Ramezani, Hesam Alizade, Maryam Baazm and Mehdi Hassaniazad. Their work appears in journals such as The Lancet, Nature, Molecular Biology Reports, PLoS ONE and Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.